Large-scale cytorrhyctes compound purifying technology for recombining tPA derivative
A technology of inclusion body and volume, applied in the field of bioengineering, can solve the problems of lack and insufficient production technology
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0062] Refolding of inclusion bodies of tissue plasminogen activator
[0063] The purified tPA inclusion bodies with a wet weight of 10 g were dissolved in 1000 ml of denaturing solution (8M urea or 7M guanidine hydrochloride, 20 mM DDT), stirred at room temperature for 2-5 hours, and then centrifuged at 15,000 rpm for 50 minutes.
[0064] Dilute the centrifuged supernatant into 8-12 liters of refolding solution I (3-7M urea, 0.5-1M arginine, 50mM Tris HCl, pH8.2-9.0, 1-10mM reduced glutathione GSH, 0.05-5mM oxidized glutathione (GSSG). After stirring overnight at room temperature, filter through a 0.45 μm filter.
[0065] Dilute the filtrate into 80-120 liters of refolding solution II (0.1-2.5M urea, 0.3-1M arginine, 50mM Tris·HCl, pH8.2-9.0). Refold at room temperature for 16-20 hours.
[0066] Filtrate (membrane specification 0.22um), and concentrate the filtrate to 3-10 liters by ultrafiltration with a 10K-Millipore ultrafiltration membrane to obtain the first concentra...
Embodiment 2
[0070] Purification of inclusion bodies of tissue plasminogen activator
[0071] In this example, the second concentrated solution containing tissue plasminogen activator prepared in Example 1 was purified by conventional ion column chromatography.
[0072] method:
[0073] Put the renatured sample obtained in Example 1 on the Pharmacia SP-Sepharose Fast Flow column, and then use the eluting solution I (50mM ammonium acetate pH4.0-5.0 containing 0-1M NaCl) to elute after loading, and then elute with Solution II (containing 0-1M arginine, 0.1-1M NaCl in 50mM ammonium acetate pH4.5-6.0) and eluting solution III (containing 0.1-1M arginine, 0.1-1M NaCl in 50mM ammonium acetate pH5.5 -7.0) eluted to obtain purified recombinant tPA derivatives.
[0074] result:
[0075] Finally, about 150-200 mg of purified recombinant tPA derivatives with a specific activity of 40,000-200,000 IU / mg protein were obtained. The amount of glutathione used in the refolding process has been reduced ...
Embodiment 3-5
[0077] Refolding of inclusion bodies of tissue plasminogen activator
[0078] Repeat Example 1, the difference is to change part of the renaturation conditions in Example 1, as shown in Table 1.
[0079] Example 1
Example 3
Example 4
Example 5
First
Refolding
liquid
Glutathione concentration
6mM
1.5mM
12mM
15mM
Reduced Glutathione:
5∶1
6∶1
5∶1
4∶1
denaturant concentration
3M urea
5M urea
Arginine concentration
0.5M
0.5M
0.5M
1M
pH
8.2-8.5
8.0
8.5
7.8
second
Refolding
liquid
pH
8.2-8.5
8.5
8.0
8.8
denaturant concentration
0.2M urea
0.5M urea
1M urea
2.5M urea
Arginine concentration
0.3M
0.3M
0.5M
1M
[0080] r...
PUM
Property | Measurement | Unit |
---|---|---|
molecular weight | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com